Enhancing human nucleus pulposus cells for biological treatment approaches of degenerative intervertebral disc diseases: A systematic review

Journal of Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 12, 2014, Pages 925-936

  Mern, Demissew Shenegelegn ^a   Beierfuß, Anja ^b   Thomé, Claudius ^a   Hegewald, Aldemar Andres ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Growth factors; Human cell culture; Intervertebral disc; Nucleus pulposus; Regeneration; Tissue engineering

Indexed keywords

BIOSYNTHESIS; BONE; CELL ENGINEERING; FRACTURE MECHANICS; SEARCH ENGINES; TISSUE REGENERATION;

BIOACTIVE FACTOR; BIOLOGICAL TREATMENT; DISK CELLS; GROWTH FACTOR; IN-VITRO; INTERVERTEBRAL DISK; NUCLEUS PULPOSUS; REGENERATION; SYSTEMATIC REVIEW; TISSUES ENGINEERINGS;

CELL CULTURE;

ADENOVIRUS VECTOR; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 12; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; INTERLEUKIN 1; MESSENGER RNA; SMALL INTERFERING RNA; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ALLOTRANSPLANTATION; ANNULUS FIBROSUS; ARTICLE; AUTOTRANSPLANTATION; BIOLOGICAL THERAPY; CELL AGING; CELL BASED GENE THERAPY; CELL DEGENERATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL MANIPULATION; CELL PROLIFERATION; CELL STIMULATION; CELL TRANSPLANTATION; CHONDROCYTE; COCULTURE; CYTOLOGY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK DISEASE; LUMBAR SPINE; NONHUMAN; NUCLEUS PULPOSUS; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; SPINAL CORD ATROPHY; STRUCTURAL GENE; SYSTEMATIC REVIEW; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; INTERVERTEBRAL DISC DEGENERATION; RISK FACTOR;

HUMANS; INTERVERTEBRAL DISC DEGENERATION; RISK FACTORS; TISSUE ENGINEERING;

EID: 84919348531     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1583     Document Type: Article

References (105)

1. Adams MA, Dolan P. 2005; Spine biomechanics. J Biomech 38: 1972-1983.
2. Adams MA, Roughley PJ. 2006; What is intervertebral disc degeneration, and what causes it? Spine 31: 2151-2161.
3. Afione SA, Wang J, Walsh S, et al. 1999; Delayed expression of adeno-associated virus vector DNA. Intervirology 42: 213-220.
4. Alini M, Eisenstein SM, Ito K, et al. 2008; Are animal models useful for studying human disc disorders/degeneration? Eur Spine J 17: 2-19.
5. An HS, Masuda K, Cs-Szabo G, et al. 2011; Biologic repair and regeneration of the intervertebral disk. J Am Acad Orthop Surg 19: 450-452.
6. Barth M, Weiss C, Thomé C. 2008; Two-year outcome after lumbar microdiscectomy versus microscopic sequestrectomy: part 1: evaluation of clinical outcome. Spine 33: 265-272.
7. Battié MC, Videman T, Kaprio J, et al. 2009; The Twin Spine Study: contributions to a changing view of disc degeneration. Spine J 9: 47-59.
8. Benneker LM, Heini PF, Alini M, et al. 2005; 2004 Young Investigator Award winner: vertebral endplate marrow contact channel occlusions and intervertebral disc degeneration. Spine 30: 167-173.
9. Bibby SR, Fairbank JC, Urban MR, et al. 2002; Cell viability in scoliotic discs in relation to disc deformity and nutrient levels. Spine 27: 2220-2228; discussion, 2227-2228.
10. Bibby SR, Urban JP. 2004; Effect of nutrient deprivation on the viability of intervertebral disc cells. Eur Spine J 13: 695-701.
11. Bibby SR, Jones DA, Ripley RM, et al. 2005; Metabolism of the intervertebral disc: effects of low levels of oxygen, glucose, and pH on rates of energy metabolism of bovine nucleus pulposus cells. Spine 30: 487-496.
12. Buckwalter JA. 1995; Aging and degeneration of the human intervertebral disc. Spine 20: 1307-1314.
13. Burke JG, Watson RW, McCormack D, et al. 2002; Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 84: 196-201.
14. Chan BP, Leong KW. 2008; Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J 17(suppl 4): 467-479.
15. Chen D, Zhao M, Mundy GR. 2004; Bone morphogenetic proteins. Growth Factors 22: 233-241.
16. Chen WH, Lo WC, Lee JJ, et al. 2006; Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-β1 in platelet-rich plasma. J Cell Physiol 209: 744-754.
17. Driesse MJ, Esandi MC, Kros JM, et al. 2000; Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity. Gene Ther 7: 1401-1409.
18. Everts PA, Knape JT, Weibrich G, et al. 2006; Platelet-rich plasma and platelet gel: a review. J Extracorpor Technol 38: 174-187.
19. Franscini N, Wuertz K, Patocchi-Tenzer I, et al. 2011; Development of a novel automated cell isolation, expansion, and characterization platform. J Lab Autom 16: 204-213.
20. Freemont AJ, Peacock TE, Goupille P, et al. 1997; Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 350: 178-181.
21. Ganey T, Libera J, Moos V, et al. 2003; Disc chondrocyte transplantation in a canine model: a treatment for degenerated or damaged intervertebral disc. Spine 28: 2609-2620.
22. Gilbertson L, Ahn SH, Teng PN, et al. 2008; The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells. Spine J 8: 449-456.
23. Gruber HE, Johnson TL, Leslie K, et al. 2002; Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine 27: 1626-1633.
24. Gruber HE, Ingram JA, Norton HJ, et al. 2007; Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated β-galactosidase in human and sand rat discs. Spine 32: 321-327.
25. Grunhagen T, Wilde G, Soukane DM, et al. 2006; Nutrient supply and intervertebral disc metabolism. J Bone Joint Surg Am 88(suppl 2): 30-35.
26. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. 2003; LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
27. Handa T, Ishihara H, Ohshima H, et al. 1997; Effects of hydrostatic pressure on matrix synthesis and matrix metalloproteinase production in the human lumbar intervertebral disc. Spine 22: 1085-1091.
28. Hastreiter D, Ozuna RM, Spector M. 2001; Regional variations in certain cellular characteristics in human lumbar intervertebral discs, including the presence of α-smooth muscle actin. J Orthop Res 19: 597-604.
29. Hegewald AA, Ringe J, Sittinger M, et al. 2008; Regenerative treatment strategies in spinal surgery. Front Biosci 13: 1507-1525.
30. Hegewald AA, Endres M, Abbushi A, et al. 2011a; Adequacy of herniated disc tissue as a cell source for nucleus pulposus regeneration. J Neurosurg Spine 14: 273-280.
31. Hegewald AA, Enz A, Endres M, et al. 2011b; Engineering of polymer-based grafts with cells derived from human nucleus pulposus tissue of the lumbar spine. J Tissue Eng Regen Med 5: 275-282.
32. Hoyland JA, Le Maitre C, Freemont AJ. 2008; Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxf) 47: 809-814.
33. Imai Y, Miyamoto K, An HS, et al. 2007; Recombinant human osteogenic protein-1 upregulates proteoglycan metabolism of human anulus fibrosus and nucleus pulposus cells. Spine 32: 1303-1309.
34. Ishii T, Tsuji H, Sano A, et al. 1991; Histochemical and ultrastructural observations on brown degeneration of human intervertebral disc. J Orthop Res 9: 78-90.
35. Jin H, Shen J, Wang B, et al. 2011; TGFβ signaling plays an essential role in the growth and maintenance of intervertebral disc tissue. FEBS Lett 585: 1209-1215.
36. Kalb S, Martirosyan NL, Kalani MYS, et al. 2012; Genetics of the degenerated intervertebral disc. World Neurosurg 77: 491-501.
37. Kandel R, Roberts S, Urban JP. 2008; Tissue engineering and the intervertebral disc: the challenges. Eur Spine J 17(suppl 4): 480-491.
38. Kanemoto M, Hukuda S, Komiya Y, et al. 1996; Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 human intervertebral discs. Spine 21: 1-8.
39. Kaneyama S, Nishida K, Takada T, et al. 2008; Fas ligand expression on human nucleus pulposus cells decreases with disc degeneration processes. J Orthop Sci 13: 130-135.
40. Kaps C, Frauenschuh S, Endres M, et al. 2006; Gene expression profiling of human articular cartilage grafts generated by tissue engineering. Biomaterials 27: 3617-3630.
41. Kim DJ, Moon SH, Kim H, et al. 2003; Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine 28: 2679-2684.
42. Kluba T, Niemeyer T, Gaissmaier C, et al. 2005; Human annulus fibrosis and nucleus pulposus cells of the intervertebral disc: effect of degeneration and culture system on cell phenotype. Spine 30: 2743-2748.
43. Lattermann C, Oxner WM, Xiao X, et al. 2005; The adeno-associated viral vector as a strategy for intradiscal gene transfer in immune competent and pre-exposed rabbits. Spine 30: 497-504.
44. Lee JY, Hall R, Pelinkovic D, et al. 2001; New use of a three-dimensional pellet culture system for human intervertebral disc cells: initial characterization and potential use for tissue engineering. Spine 26: 2316-2322.
45. Le Maitre CL, Freemont AJ, Hoyland JA. 2005; The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7: R732-745.
46. Le Maitre CL, Freemont AJ, Hoyland JA. 2009; Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells. Arthritis Res Ther 11: R137.
47. Leung VY, Tam V, Chan D, et al. 2011; Tissue engineering for intervertebral disk degeneration. Orthop Clin North Am 42: 575-583.
48. Le Visage C, Kim SW, Tateno K, et al. 2006a; Interaction of human mesenchymal stem cells with disc cells: changes in extracellular matrix biosynthesis. Spine 31: 2036-2042.
49. Le Visage C, Yang SH, Kadakia L, et al. 2006b; Small intestinal submucosa as a potential bioscaffold for intervertebral disc regeneration. Spine 31: 2423-2430.
50. Liebscher T, Haefeli M, Wuertz K, et al. 2011; Age-related variation in cell density of human lumbar intervertebral discs. Spine 36: 153-159.
51. Lotz JC. 2004; Animal models of intervertebral disc degeneration: lessons learned. Spine 29: 2742-2750.
52. Lozier JN, Csako G, Mondoro TH, et al. 2002; Toxicity of a first-generation adenoviral vector in rhesus macaques. Hum Gene Ther 13: 113-124.
53. Malfait AM, Liu RQ, Ijiri K, et al. 2002; Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 277: 22201-22208.
54. Maroudas A, Stockwell RA, Nachemson A, et al. 1975; Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. J Anat 120: 113-130.
55. Masuda K, Oegema TR, An HS. 2004; Growth factors and treatment of intervertebral disc degeneration. Spine 29: 2757-2769.
56. Mauth C, Bono E, Haas S, et al. 2009; Cell-seeded polyurethane-fibrin structures - a possible system for intervertebral disc regeneration. Eur Cell Mater 18: 27-38; discussion, 38-39.
57. Mazzolini G, Narvaiza I, Pérez-Diez A, et al. 2001; Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12. Gene Ther 8: 259-267.
58. McNally DS, Shackleford IM, Goodship AE, et al. 1996; In vivo stress measurement can predict pain on discography. Spine 21: 2580-2587.
59. Meisel HJ, Ganey T, Hutton WC, et al. 2006; Clinical experience in cell-based therapeutics: intervention and outcome. Eur Spine J 15(suppl 3): 397-405.
60. Moon SH, Nishida K, Gilbertson LG, et al. 2008; Biologic response of human intervertebral disc cells to gene therapy cocktail. Spine 33: 1850-1855.
61. Mulleman D, Mammou S, Griffoul I, et al. 2006; Pathophysiology of disk-related sciatica. I. Evidence supporting a chemical component. Joint Bone Spine 73: 151-158.
62. Naito S, Shiomi T, Okada A, et al. 2007; Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage. Pathol Int 57: 703-711.
63. Neidlinger-Wilke C, Mietsch A, Rinkler C, et al. 2012; Interactions of environmental conditions and mechanical loads have influence on matrix turnover by nucleus pulposus cells. J Orthop Res 30: 112-121.
64. Neidlinger-Wilke C, Würtz K, Liedert A, et al. 2005; A three-dimensional collagen matrix as a suitable culture system for the comparison of cyclic strain and hydrostatic pressure effects on intervertebral disc cells. J Neurosurg Spine 2: 457-465.
65. Nemunaitis J, Cunningham C, Buchanan A, et al. 2001; Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Ther 8: 746-759.
66. Nicodemus GD, Bryant SJ. 2008; Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev 14: 149-165.
67. Nishida K, Kang JD, Gilbertson LG, et al. 1999; Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor-β1 encoding gene. Spine 24: 2419-2425.
68. Nishida K, Doita M, Takada T, et al. 2006; Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy. Spine 31: 1415-1419.
69. Nomura T, Mochida J, Okuma M, et al. 2001; Nucleus pulposus allograft retards intervertebral disc degeneration. Clin Orthop Relat Res 389: 94-101.
70. Ohshima H, Urban JP. 1992; The effect of lactate and pH on proteoglycan and protein synthesis rates in the intervertebral disc. Spine 17: 1079-1082.
71. Okuma M, Mochida J, Nishimura K, et al. 2000; Reinsertion of stimulated nucleus pulposus cells retards intervertebral disc degeneration: an in vitro and in vivo experimental study. J Orthop Res 18: 988-997.
72. Panjabi MM, Krag MH, Chung TQ. 1984; Effects of disc injury on mechanical behavior of the human spine. Spine 9: 707-713.
73. Panjabi MM. 2003; Clinical spinal instability and low back pain. J Electromyogr Kinesiol 13: 371-379.
74. Peng B, Wu W, Hou S, et al. 2005; The pathogenesis of discogenic low back pain. J Bone Joint Surg Br 87: 62-67.
75. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
76. Preradovic A, Kleinpeter G, Feichtinger H, et al. 2005; Quantitation of collagen I, collagen II and aggrecan mRNA and expression of the corresponding proteins in human nucleus pulposus cells in monolayer cultures. Cell Tissues Res 321: 459-464.
77. Richardson SM, Walker RV, Parker S, et al. 2006; Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells 24: 707-716.
78. Robbins PD, Ghivizzani SC. 1998; Viral vectors for gene therapy. Pharmacol Ther 80: 35-47.
79. Roberts S, Caterson B, Menage J, et al. 2000; Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 25: 3005-3013.
80. Roberts S, Evans EH, Kletsas D, et al. 2006; Senescence in human intervertebral discs. Eur Spine J 15(suppl 3): S312-316.
81. Roughley PJ. 2004; Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine 29: 2691-2699.
82. Seki S, Asanuma-Abe Y, Masuda K, et al. 2009; Effect of small interference RNA (siRNA) for ADAMTS5 on intervertebral disc degeneration in the rabbit anular needle-puncture model. Arthritis Res Ther 11: R166.
83. Setton LA, Chen J. 2006; Mechanobiology of the intervertebral disc and relevance to disc degeneration. J Bone Joint Surg Am 88(suppl 2): 52-57.
84. Sohn P, Cox M, Chen D, et al. 2010; Molecular profiling of the developing mouse axial skeleton: a role for Tgfbr2 in the development of the intervertebral disc. BMC Dev Biol 10: 29.
85. Stern S, Lindenhayn K, Perka C. 2004; Human intervertebral disc cell culture for disc disorders. Clin Orthop Relat Res 419: 238-244.
86. Strassburg S, Richardson SM, Freemont AJ, et al. 2010; Co-culture induces mesenchymal stem cell differentiation and modulation of the degenerate human nucleus pulposus cell phenotype. Regen Med 5: 701-711.
87. Urban JP, Holm S, Maroudas A, et al. 1977; Nutrition of the intervertebral disk. An in vivo study of solute transport. Clin Orthop Relat Res 129: 101-114.
88. Urban JP, McMullin JF. 1988; Swelling pressure of the lumbar intervertebral discs: influence of age, spinal level, composition, and degeneration. Spine 13: 179-187.
89. Urban JP, Smith S, Fairbank JC. 2004; Nutrition of the intervertebral disc. Spine 29: 2700-2709.
90. Vadalà G, Sowa GA, Smith L, et al. 2007; Regulation of transgene expression using an inducible system for improved safety of intervertebral disc gene therapy. Spine 32: 1381-1387.
91. Vadalà G, Studer RK, Sowa G, et al. 2008; Coculture of bone marrow mesenchymal stem cells and nucleus pulposus cells modulate gene expression profile without cell fusion. Spine 33: 870-876.
92. Videman T, Sarna S, Battié MC, et al. 1995; The long-term effects of physical loading and exercise lifestyles on back-related symptoms, disability, and spinal pathology among men. Spine 20: 699-709.
93. Wallach CJ, Sobajima S, Watanabe Y, et al. 2003; Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 28: 2331-2337.
94. Wallach CJ, Kim JS, Sobajima S, et al. 2006; Safety assessment of intradiscal gene transfer: a pilot study. Spine J 6: 107-112.
95. Wang ZH, Yang ZQ, He XJ, et al. 2008; Effects of RNAi-mediated inhibition of aggrecanase-1 and aggrecanase-2 on rat costochondral chondrocytes in vitro. Acta Pharmacol Sin 29: 1215-1226.
96. Wang ZH, Yang ZQ, He XJ, et al. 2010; Lentivirus-mediated knockdown of aggrecanase-1 and -2 promotes chondrocyte-engineered cartilage formation in vitro. Biotechnol Bioeng 107: 730-736.
97. Watanabe T, Sakai D, Yamamoto Y, et al. 2010; Human nucleus pulposus cells significantly enhanced biological properties in a co-culture system with direct cell-to-cell contact with autologous mesenchymal stem cells. J Orthop Res 28: 623-630.
98. West MD, Pereira-Smith OM, Smith JR. 1989; Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res 184: 138-147.
99. Yang SH, Chen PQ, Chen YF, et al. 2005a; Gelatin/chondroitin-6-sulfate copolymer scaffold for culturing human nucleus pulposus cells in vitro with production of extracellular matrix. J Biomed Mater Res B Appl Biomater 74: 488-494.
100. Yang SH, Chen PQ, Chen YF, et al. 2005b; An in vitro study on regeneration of human nucleus pulposus by using gelatin/chondroitin-6-sulfate/hyaluronan tri-copolymer scaffold. Artif Organs 29: 806-814.
101. Yang SH, Wu CC, Shih TT, et al. 2008a; Three-dimensional culture of human nucleus pulposus cells in fibrin clot: comparisons on cellular proliferation and matrix synthesis with cells in alginate. Artif Organs 32: 70-73.
102. Yang SH, Wu CC, Shih TT, et al. 2008b; In vitro study on interaction between human nucleus pulposus cells and mesenchymal stem cells through paracrine stimulation. Spine 33: 1951-1957.
103. Yang SH, Lin CC, Hu MH, et al. 2010; Influence of age-related degeneration on regenerative potential of human nucleus pulposus cells. J Orthop Res 28: 379-383.
104. Yang Y, Nunes FA, Berencsi K, et al. 1994; Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407-4411.
105. Zeiter S, van der Werf M, Ito K. 2009; The fate of bovine bone marrow stromal cells in hydrogels: a comparison to nucleus pulposus cells and articular chondrocytes. J Tissue Eng Regen Med 3: 310-320.